Article
CDC expedites release of 77,000 additional doses of Sanofi-AstraZeneca's RSV drug
Rating:
0.0
Views:
39
Likes:
1
Library:
1
The U.S. Centers for Disease Control and Prevention said on Thursday it has expedited the release of more than 77,000 additional doses of Sanofi and AstraZeneca's respiratory syncytial virus (RSV) drug Beyfortus.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value